JP7576048B2 - 新規なペプチド化合物またはその薬学的に許容される塩 - Google Patents

新規なペプチド化合物またはその薬学的に許容される塩 Download PDF

Info

Publication number
JP7576048B2
JP7576048B2 JP2021568962A JP2021568962A JP7576048B2 JP 7576048 B2 JP7576048 B2 JP 7576048B2 JP 2021568962 A JP2021568962 A JP 2021568962A JP 2021568962 A JP2021568962 A JP 2021568962A JP 7576048 B2 JP7576048 B2 JP 7576048B2
Authority
JP
Japan
Prior art keywords
stirred
injected
substituted
unsubstituted
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021568962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533991A (ja
JP2022533991A5 (https=
Inventor
ユ ソク キム
ミョン ファン キム
ユン イン キム
テク ジュー リム
ヒョン ジュン リム
ジェ ヨン キム
ウン ヨン パク
Original Assignee
アイバイオ コリア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイバイオ コリア filed Critical アイバイオ コリア
Publication of JP2022533991A publication Critical patent/JP2022533991A/ja
Publication of JP2022533991A5 publication Critical patent/JP2022533991A5/ja
Application granted granted Critical
Publication of JP7576048B2 publication Critical patent/JP7576048B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/55—Peptide, protein hydrolysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
JP2021568962A 2019-05-21 2020-05-20 新規なペプチド化合物またはその薬学的に許容される塩 Active JP7576048B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2019-0059628 2019-05-21
KR20190059628 2019-05-21
PCT/KR2020/006594 WO2020235932A1 (ko) 2019-05-21 2020-05-20 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Publications (3)

Publication Number Publication Date
JP2022533991A JP2022533991A (ja) 2022-07-27
JP2022533991A5 JP2022533991A5 (https=) 2023-05-25
JP7576048B2 true JP7576048B2 (ja) 2024-10-30

Family

ID=73458705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568962A Active JP7576048B2 (ja) 2019-05-21 2020-05-20 新規なペプチド化合物またはその薬学的に許容される塩

Country Status (15)

Country Link
US (2) US12428446B2 (https=)
EP (2) EP3974441B1 (https=)
JP (1) JP7576048B2 (https=)
KR (2) KR20200134175A (https=)
CN (1) CN114269769B (https=)
AU (1) AU2020277930B2 (https=)
BR (1) BR112021023477A2 (https=)
CA (1) CA3139411A1 (https=)
ES (1) ES3012499T3 (https=)
MX (1) MX2021014051A (https=)
MY (1) MY205382A (https=)
PL (1) PL3974441T3 (https=)
SG (1) SG11202112276RA (https=)
WO (1) WO2020235932A1 (https=)
ZA (1) ZA202109175B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR20230089987A (ko) 2021-12-14 2023-06-21 주식회사 아이바이오코리아 펩타이드 약물을 포함하는 안구 투여용 약학 조성물
WO2023224454A1 (ko) 2022-05-20 2023-11-23 주식회사 엘지화학 양극 활물질 및 이의 제조방법
KR102587729B1 (ko) 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102728422B1 (ko) * 2024-05-27 2024-11-11 주식회사 아이바이오코리아 염증성 질환의 치료 효과를 갖는 신규한 펩타이드 및 이의 용도

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528500A (ja) 2005-01-20 2008-07-31 バイオマーク・フアーマシユーテイカルズ・リミテツド Ｍａｎｓの構造に基づくムチン過剰分泌抑制剤及び使用方法
WO2008111063A2 (en) 2007-03-12 2008-09-18 Ramot At Tel Aviv University Ltd. Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions
US20090074672A1 (en) 2007-09-17 2009-03-19 Sri International Tumor Boundary Imaging
WO2011060349A1 (en) 2009-11-13 2011-05-19 North Carolina State University Methods of modulating mesenchymal stem cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
IT1241761B (it) * 1990-08-03 1994-02-01 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2004074312A2 (en) * 2003-02-05 2004-09-02 University Of Ulster Tryptophyllin peptides and uses thereof
AU2008297541A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
JP5299956B2 (ja) 2008-09-29 2013-09-25 国立大学法人東北大学 質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド
CA2869599C (en) * 2012-04-13 2021-07-27 Lubrizol Advanced Materials, Inc. Compounds which inhibit neuronal exocytosis (ii)
WO2013158230A1 (en) 2012-04-19 2013-10-24 The Regents Of The University Of California Compositions and methods for detecting unstable arteriosclerotic plaques
KR101438744B1 (ko) 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101721059B1 (ko) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101810163B1 (ko) 2016-04-08 2018-01-25 주식회사 아이바이오코리아 안구 표면질환 예방 또는 치료용 약학조성물
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
EP3539559B1 (en) 2016-04-08 2020-08-26 Eyebio Korea Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration
KR101795650B1 (ko) 2016-05-12 2017-11-09 인제대학교 산학협력단 아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
JP2019524673A (ja) * 2016-06-28 2019-09-05 バロリゼーション−ルシェルシュ，リミテッド パートナーシップ 新規な環状ペプチドおよびその使用
HUP1700012A2 (en) * 2017-01-06 2018-07-30 Evolveritas Kft Novel proteins and use thereof
EP3609519B1 (en) * 2017-04-11 2025-11-26 University of Maryland, Baltimore Compositions and methods for treating inflammation and cancer
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
CN107814840B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽pkypvepf及其制备方法和应用
CN108727472A (zh) * 2018-06-07 2018-11-02 南方医科大学 带负电荷的细胞穿透肽及作为细胞内运送载体的用途
TWI865470B (zh) 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528500A (ja) 2005-01-20 2008-07-31 バイオマーク・フアーマシユーテイカルズ・リミテツド Ｍａｎｓの構造に基づくムチン過剰分泌抑制剤及び使用方法
WO2008111063A2 (en) 2007-03-12 2008-09-18 Ramot At Tel Aviv University Ltd. Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions
US20090074672A1 (en) 2007-09-17 2009-03-19 Sri International Tumor Boundary Imaging
WO2011060349A1 (en) 2009-11-13 2011-05-19 North Carolina State University Methods of modulating mesenchymal stem cells

Also Published As

Publication number Publication date
EP4483959A3 (en) 2025-06-04
EP4483959A2 (en) 2025-01-01
SG11202112276RA (en) 2021-12-30
KR102523943B1 (ko) 2023-04-20
CN114269769B (zh) 2024-12-06
EP3974441A1 (en) 2022-03-30
PL3974441T3 (pl) 2025-04-07
EP3974441B1 (en) 2024-12-04
KR20200134175A (ko) 2020-12-01
EP3974441A4 (en) 2023-10-18
CA3139411A1 (en) 2020-11-26
ES3012499T3 (en) 2025-04-09
ZA202109175B (en) 2024-04-24
WO2020235932A1 (ko) 2020-11-26
BR112021023477A2 (pt) 2022-02-15
US20240228538A1 (en) 2024-07-11
KR20220062252A (ko) 2022-05-16
US12428446B2 (en) 2025-09-30
JP2022533991A (ja) 2022-07-27
MX2021014051A (es) 2022-02-11
AU2020277930B2 (en) 2024-06-13
CN114269769A (zh) 2022-04-01
US20240352071A1 (en) 2024-10-24
MY205382A (en) 2024-10-18
AU2020277930A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
JP7576048B2 (ja) 新規なペプチド化合物またはその薬学的に許容される塩
JP2018524398A (ja) 筋肉疾患の予防、改善または治療用または筋機能改善用組成物
KR101957014B1 (ko) 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
KR101710474B1 (ko) 갈아마이드 유도체 및 이의 용도
KR101980897B1 (ko) Ll37 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR102124986B1 (ko) 익모초 추출물 또는 레오누린을 함유하는 근육 질환 예방 또는 치료용 또는 근 기능 개선용 조성물
KR102158036B1 (ko) Pseudin-2 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
WO2017119481A1 (ja) 環状ジペプチド含有神経性疾患予防用組成物
KR102032945B1 (ko) 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
KR102353335B1 (ko) 무궁화 에탄올 추출물의 분획물을 포함하는 tlr4-md2 저해제 조성물
KR101594115B1 (ko) 1,2,4,5-tetramethoxybenzene을 유효성분으로 포함하는 알레르기 질환의 예방 또는 치료용 조성물
JP2023501136A (ja) クルクミノイド及び甘草抽出物またはその分画物を含有するブタ流行性下痢ウイルス感染の予防または治療用組成物
RU2824612C2 (ru) Новое пептидное соединение или его фармацевтически приемлемая соль
KR101830395B1 (ko) 스쿠알렌을 함유하는 근기능 향상 및 근육 손상 예방용 조성물
KR20200134153A (ko) 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
HK40068628A (en) Novel peptide compound or pharmaceutically acceptable salt thereof
JP7161170B2 (ja) 亜鉛トランスポーター発現促進剤
HK40068628B (zh) 新型肽化合物或其药学上可接受的盐
JP7606175B2 (ja) Ｉｌ－８産生抑制用及び／又はコラゲナーゼ産生抑制用組成物及びその製造方法
KR101150485B1 (ko) 알코니아 트리플너비아 추출물을 함유하는 천식 또는 염증성 질환의 예방 및 치료용 약학적 조성물
JP2014101329A (ja) 抗炎症剤
JP2017088553A (ja) 抗糖化剤
JP7180854B2 (ja) 亜鉛トランスポーター発現促進剤
JP2023044235A (ja) イムノグロブリンａ産生促進用組成物
KR20250131910A (ko) 헴프 추출물 및 해파리 가수분해물의 혼합물을 유효성분으로 함유하는 항염증 및 피부 재생용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230516

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230516

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240430

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240723

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240723

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240723

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241015

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241018

R150 Certificate of patent or registration of utility model

Ref document number: 7576048

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150